Skip to main content
. 2015 Aug 24;8(4):e3434. doi: 10.17795/ijcp-3434

Table 3. Distribution of Genotypes and Allele Frequencies of IL-10 (A -1082 G) Promoter Polymorphism With Respect to Early Stage and Late Stage Breast Cancer.

Genotype Early Stage Breast Cancer Late Stage Breast Cancer
Disease (N = 46) Control (N = 160) P Value χ2 OR (95% CI) Disease (N = 52) Control (N = 160) P Value χ2 OR (95% CI)
Co-Dominant
AA 28 (60.86) 67 (41.87) 33 (63.46) 67 (41.87)
AG 13 (28.26) 78 (48.75) 0.02029 a 2.507 (1.203 - 5.226) 11 (21.15) 78 (48.75) 0.0014 a 3.493 (1.639 -7.441)
GG 5 (10.86) 15 (9.375) 0.896 1.254 (0.415- 3.781) 8 (15.38) 15 (9.375) 0.9348 0.9235 (0.355 -2.397)
Allele
A 69 (75.0) 212 (66.25) 77 (74.03) 212 (66.25)
G 23 (25.0) 108 (33.75) 0.144 1.528 (0.903 - 2.585) 27 (25.96) 108 (33.75) 0.174 1.453 (0.884 -2.385)
Dominant
AA 28 (60.86) 67 (41.87) 33 (63.46) 67 (41.87)
AG + GG 18 (39.13) 93 (58.12) 0.03488 a 2.159 (1.105 -4.221) 19 (36.53) 93 (58.12) 0.0108 a 2.411 (1.264 -4.599)
Recessive
AA + AG 41 (89.13) 145 (90.62) 44 (84.61) 145 (90.62)
GG 5 (10.86) 15 (9.375) 0.9847 0.848 (0.291-2.473) 8 (15.38) 15 (9.37) 0.569 (0.226 -1.43)
Over Dominant
AA + GG 33 (71.74) 82 (51.25) 41 (78.84) 82 (51.25)
AG 13 (28.26) 78 (48.75) 0.02158 a 2.415(1.184 -4.925) 11 (21.15) 78 (48.75) 0.0008 a 3.545(1.702 -7.388)

a P ≤ 0.05.